CHG-2021-0284
Facility Change for Glucovantib. Facility Change for Glucovantib — critical change. Impacts 7 markets and 1 variations.
Change Number
CHG-2021-0284
Type
Facility Change
Product
Status
Active
Owner
Lieselotte van der Berg
Initiated
2023-12-09
Description
Facility Change for Glucovantib — critical change
Impacted Markets (7)
BR — BrazilCA — CanadaGB — United KingdomIN — IndiaZA — South AfricaPL — PolandPT — Portugal
Impacted Modules
5.3.5
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|